Premium
Early prophylaxis/FVIII tolerization regimen that avoids immunological danger signals is still effective in minimizing FVIII inhibitor developments in previously untreated patients – long‐term follow‐up and continuing experience
Author(s) -
AUERSWALD G.,
BIDLINGMAIER C.,
KURNIK K.
Publication year - 2012
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/j.1365-2516.2011.02659.x
Subject(s) - medicine , regimen , pediatrics